PAR12 ABATACEPT (CTLA4IG) IN COMBINATION WITH METHOTREXATE DEMONSTRATES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES OVER TWO YEARS IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE
作者
T Li,Ross Maclean,Isaac F. Nuamah,Jean-Claude Becker
出处
期刊:Value in Health [Elsevier BV] 日期:2005-05-01卷期号:8 (3): 343-343